LIG4 Mutation Model Ties DNA Repair Failure to Severe Intestinal Inflammation
A hypomorphic LIG4 mutation can do more than weaken genome maintenance. In mice carrying the patient-derived p.W447C missense variant, defective DNA double-strand break repair produced growth retardation, increased radiosensitivity, and severe intestinal inflammation layered on top of profound adaptive immunodeficiency.
The phenotype is striking because inflammation has been difficult to reproduce consistently in other models of defective double-strand break repair. Here, the intestinal disease emerged only in the setting of severe immune dysfunction, suggesting that impaired lymphocyte development and abnormal antigen receptor formation can tilt the gut toward destructive immune activation rather than simple immune failure.
A Patient Variant Recreated in Mice
DNA ligase IV is required for repair of DNA double-strand breaks, a process essential for lymphocyte development because antigen receptor genes must be rearranged with precision. When that machinery falters, the consequences extend beyond genomic instability. Hypomorphic variants in LIG4 cause LIG4 syndrome, a condition linked to growth disturbance, radiosensitivity, malignancy risk, adaptive immunodeficiency, and inflammatory disease.
The mouse line in this study carried the same missense variant found in a patient with LIG4 syndrome. That design matters because it moves the biology out of abstraction and into a genotype with direct human relevance. The homozygous Lig4W447C/W447C mice showed functional defects of LIGIV, confirming that the mutation compromised the protein’s repair role rather than merely marking a benign sequence change.
The result was not a narrow molecular phenotype. The animals exhibited systemic vulnerability, with impaired growth and heightened sensitivity to radiation, then progressed to life-threatening intestinal inflammation. For a disease rooted in DNA repair, the gastrointestinal tract became the organ where immune imbalance was most visibly expressed.
Th1-Dominant Gut Disease Emerged Under Adaptive Immunodeficiency
The intestinal inflammation depended on lymphocytes. Within the inflamed tissue, the dominant cellular signature was a marked infiltration of Th1 cells and macrophages, accompanied by increased expression of IFN-γ–inducible genes. Those findings point to a canonical type 1 inflammatory circuit, in which IFN-γ–driven immune activation recruits and sustains macrophage-rich tissue injury.
One sentence captures the core biology: a defect in DNA repair redirected the immune response toward a Th1 inflammatory program in the gut.
That pattern fits the logic of defective lymphocyte development. When V(D)J recombination is abnormal, the surviving T-cell pool is not only reduced in size but also altered in composition and selection pressure. In the intestine, where tolerance and microbial exposure must be continuously balanced, even a distorted residual repertoire can become pathogenic if it is enriched for inflammatory clones.
IFN-γ Deletion Shifted the Inflammatory Program
Removing Ifng changed the shape of the response rather than eliminating it. In the absence of IFN-γ, Th2 and Th17 cells, instead of Th1 cells, drove the inflammation. The biology here is not a simple on-or-off switch; it is a rerouting of immune polarization when a dominant cytokine axis is removed.
This shift suggests that IFN-γ does more than amplify tissue injury. It also helps define which T-cell subset becomes the principal effector arm in the diseased intestine. Once that axis disappeared, the inflammatory burden persisted through alternative helper T-cell programs, revealing how flexible and adaptive the pathological response can be in an immunodeficient host.
T-Cell Receptor Repertoire Was Biased and Expanded
Single-cell RNA sequencing paired with T-cell receptor repertoire analysis added a deeper layer to the story. T cells from Lig4W447C/W447C mice preferentially used proximal Vα and Jα segments in TCRα chains, and several clonotypes expanded substantially. A meaningful portion of those expanded clones were CD4+ T cells expressing IFN-γ.
This is the most mechanistically informative part of the study. Preferential use of proximal Vα and Jα segments points to altered antigen receptor assembly, consistent with defective DNA repair during T-cell development. Clonal expansion on top of that skew suggests that the immune system is not merely underdeveloped; it is also being shaped into a restricted and potentially autoreactive or microbiota-reactive repertoire capable of driving intestinal inflammation.
In practical immunologic terms, the mutant mice carried a narrowed TCR architecture and an effector pool that was already biased toward inflammatory cytokine production. The gut, constantly exposed to antigenic stimulation, became the site where those abnormalities converged.
Why This Mouse Model Matters for Immune-Mediated Disease
This model stands out because it links a defined human LIG4 missense variant to a reproducible inflammatory phenotype. The work identifies a setting in which defective double-strand break repair does not simply cause immunodeficiency; it creates the conditions for Th1-skewed intestinal inflammation under severe adaptive immune dysfunction.
That has two implications for translational immunology. First, DNA repair defects can shape immune disease through repertoire distortion, not just through quantitative lymphocyte loss. Second, cytokine dominance may determine the inflammatory phenotype that emerges from a broken immune system, with IFN-γ acting as a key organizer of gut pathology in this model.
The study also fills a gap left by earlier defective repair models that failed to show consistent inflammation. Here, the combination of a patient-derived variant, severe adaptive immunodeficiency, cytokine profiling, and single-cell TCR analysis creates a coherent mechanistic chain from DNA ligase dysfunction to tissue-level disease.
The remaining challenge is clinical translation, because the findings come from mice rather than patients with active intestinal disease. Even so, the phenotype offers a focused experimental system for dissecting how LIG4-related immune deficiency can evolve into organ-specific inflammation, and why the intestine may be especially vulnerable when T-cell development goes awry.